Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration
Lucid Diligence Brief: AstraZeneca and CSPC obesity and T2D collaboration…
Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development
Lucid Diligence Brief: CORXEL $287m Series D1 for oral GLP-1 development…
Neuroscience Video Recap—January 21, 2026
This Neuroscience video recap highlights key developments across regulatory…
Obesity Today—January 20, 2026
This week's Obesity update covers a mix of regulatory decisions, late-stage…
Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A
Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A Professional…
AI in Healthcare and Digital Health Today—January 8, 2026
This roundup covers major developments across artificial intelligence,…
Lucid Diligence Brief: Halozyme × Skye Bioscience evaluating ENHANZE + nimacimab in obesity
Lucid Diligence Brief: Halozyme × Skye Bioscience evaluating ENHANZE +…
Endocrinology Video Recap—December 16, 2025
This biweekly endocrinology video recap covers major regulatory decisions,…
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity candidates
Lucid Diligence Brief: Prolynx $70m Series A for long-acting obesity……
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal
Lucid Diligence Brief: Pfizer YaoPharma oral GLP-1 deal Professional audiences…
Obesity Today—December 9, 2025
This week’s obesity update spotlights key developments, regulatory milestones,…
Public Health Today—5 December, 2025
This Public Health weekly update highlights new evidence shaping behavioural,…